Skip to content
Home/Companies/MedTech/Akina
Akina

Akina

MedTech·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Akina?

Akina is a Swiss MedTech company, currently owned by Freigeist Capital since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Freigeist Capital
Investor
Freigeist Capital
Freigeist Deep-Tech Evergreen · 2017 · Evergreen

Key facts

HQSwitzerland
SectorMedTech
StatusActive
Websitewww.akina.health

More from Freigeist Deep-Tech Evergreen

Other portfolio companies in the same fund.

Zahnheld
Active
Germany· 2026
Collie
Collie
Active
SoftwareGermany· 2025
BioThrust
Active
BiotechGermany· 2024
United Manufacturing Hub
Active
SoftwareGermany· 2024
Leko Labs
Active
ConstructionLuxembourg· 2022
Prosion
Prosion
Active
BiotechGermany· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Akina?

Akina is currently owned by Freigeist Capital, through Freigeist Deep-Tech Evergreen, since 2025.

When did Freigeist Capital acquire Akina?

Freigeist Capital acquired Akina in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue